Cargando…
Myocardial fibrosis occurs in non-hospitalised patients with chronic symptoms after COVID-19
Autores principales: | Krishnan, A., Ellenberger, K.A., Phetsouphanh, C., Kelleher, A.P., Matthews, G.V., Darley, D.R., Holloway, C.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789662/ https://www.ncbi.nlm.nih.gov/pubmed/35097185 http://dx.doi.org/10.1016/j.ijcha.2022.100964 |
Ejemplares similares
-
Myocardial Fibrosis Occurs in Non-Hospitalised Patients With Chronic Symptoms After COVID-19
por: Krishnan, A., et al.
Publicado: (2022) -
Radiolabeled fibroblast activation protein inhibitors in the evaluation of myocardial fibrosis
por: Su, Xiangyu, et al.
Publicado: (2023) -
Increased risk of hospitalisation and death with the delta variant in the USA
por: Bast, Elizabeth, et al.
Publicado: (2021) -
Accountability, research transparency and data reporting
por: Licker, Marc, et al.
Publicado: (2020) -
AIDS-Associated Psoriasiform Dermatitis - An Uncommonly Reported Entity Occurring Along with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Sinha, Preema, et al.
Publicado: (2021)